A detailed to-do list for SEC-registered firms to build a foundation for compliant and effective anti-money laundering ...
The brokerage industry regulator cited gaps in surveillance, customer due diligence, and red-flag escalation across the ...
Two of the largest organizations representing investment advisers and asset managers are voicing support for a federal proposal to postpone new anti-money laundering requirements for RIAs, while ...
In financial institutions across the United States, there’s a reflex that’s become almost ritual. When a regulator walks in, or a board member asks whether the AML program is working, the answer is ...
Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia ...
News-Medical.Net on MSN
Combination therapy offers hope for AML patients facing drug resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...
- Milestone triggered by dosing of first patient in frontline AML Phase 3 clinical program- Forward-Looking Statements This news release contains certain forward-looking statements that involve risks ...
Asian patients with newly diagnosed acute myeloid leukemia (AML) may have superior overall survival (OS) outcomes compared with White patients, though further data are needed to corroborate this ...
– The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers – SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback